Somatostatin analogs for the treatment of neuroendocrine tumors. - Wikidata - awgldk - TriplyDB

Somatostatin analogs for the treatment of neuroendocrine tumors.

Somatostatin analogs for the treatment of neuroendocrine tumors.

http://www.wikidata.org/entity/Q37849210

about

PI3K-AKT-mTOR-signaling and beyond: the complex network in gastroenteropancreatic neuroendocrine neoplasms The somatostatin analogue octreotide inhibits growth of small intestine neuroendocrine tumour cells Evaluation of the efficacy and safety of lanreotide in combination with targeted therapies in patients with neuroendocrine tumours in clinical practice: a retrospective cross-sectional analysis Management of controversial gastroenteropancreatic neuroendocrine tumour clinical situations with somatostatin analogues: results of a Delphi questionnaire panel from the NETPraxis program.Synergistic effect of pasireotide and teriflunomide in carcinoids in vitro.Everolimus plus octreotide long-acting repeatable in patients with colorectal neuroendocrine tumors: a subgroup analysis of the phase III RADIANT-2 study.A knockin mouse model for human ATP4aR703C mutation identified in familial gastric neuroendocrine tumors recapitulates the premalignant condition of the human disease and suggests new therapeutic strategies.Clinicopathological, treatment, and prognosis study of 43 gastric neuroendocrine carcinomas.Targeting aerobic glycolysis: 3-bromopyruvate as a promising anticancer drug.Pancreatic neuroendocrine tumors: a comprehensive review.Gastroenteropancreatic neuroendocrine tumors: update on therapeutics.Targeting the somatostatin receptor in pituitary and neuroendocrine tumors.Gastrointestinal neuroendocrine tumors (NETs): new diagnostic and therapeutic challenges.Rationale and protocol of MetNET-2 trial: Lanreotide Autogel plus metformin in advanced gastrointestinal or lung neuroendocrine tumors.Imaging, biodistribution and efficacy evaluation of 188Re-human serum albumin microspheres via intraarterial route in an orthotopic hepatoma model.Activation of somatostatin 2 receptors in the brain and the periphery induces opposite changes in circulating ghrelin levels: functional implications.Effects of octreotide therapy in progressive head and neck paragangliomas: case series.⁶⁸Ga-DOTA⁰-Tyr³-octreotide positron emission tomography in head and neck squamous cell carcinoma.Peptide receptor radionuclide therapy in a patient with disabling non-functioning pituitary adenoma.Truncated variants of pig somatostatin receptor subtype 5 (sst5) act as dominant-negative modulators for sst2-mediated signaling.Biodistribution, Pharmacokinetics and Efficacy of 188Re(I)-Tricarbonyl-Labeled Human Serum Albumin Microspheres in an Orthotopic Hepatoma Rat Model.

P2860

Q26862544-4AD14225-969A-4EAF-A81B-53BC0955A6B8 Q28484664-519BAB42-1B81-4065-9906-6D3018B7752A Q35681825-4E76E86D-C0A0-47AE-BC5C-5B0AD125E780 Q36184629-C55AD17F-0A67-4E23-A691-F4715A832679 Q36536629-FF5E2ED4-BA4D-4449-BDE1-C26A880458F8 Q36565634-1191E218-B0EA-4E11-B1A2-6E4945D032F6 Q37305896-B8DCA5BA-B1E7-498D-996A-06DB0855B0F7 Q37624511-F754839E-5912-4934-BCEA-B36ECFF24AD4 Q37983497-BF2D5DCC-B514-47D6-ACA0-7FCCB1B9B2F6 Q37995947-0475C42E-5F72-433D-B342-43F74116A69C Q38010424-CCF31C07-09F9-403D-9CB0-53601859D3BF Q38132768-8EA4F144-5D04-4C3E-8F98-F00F8C9E770D Q38175857-A233E9E1-5844-4B52-B43E-1856BFA789A2 Q38674812-88BF3751-F537-4918-89E3-ACFC43FAEC82 Q38723174-7ED51E94-FD90-4647-B650-B7D0D21A701F Q42519592-A80D812E-C000-4393-9E97-F7C1B216D96D Q43755698-4E3FAAC0-D59B-497E-807B-A3E8E0DFFA02 Q44209015-D162A138-DFB7-4B86-BC5D-FF3CCA9C73D7 Q50933634-AB5F5BF1-655A-4669-BDF7-0AB9205B646A Q51756591-8F8D65F2-6BEC-4681-A920-BA8241A33FC1 Q55504888-3B0A1EAF-98EA-4380-A2BC-B76BF765AD09

P2860

Somatostatin analogs for the treatment of neuroendocrine tumors.

http://www.wikidata.org/entity/Q37849210

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on March 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Somatostatin analogs for the treatment of neuroendocrine tumors.

@en

Somatostatin analogs for the treatment of neuroendocrine tumors.

@nl

type

label

Somatostatin analogs for the treatment of neuroendocrine tumors.

@en

Somatostatin analogs for the treatment of neuroendocrine tumors.

@nl

prefLabel

Somatostatin analogs for the treatment of neuroendocrine tumors.

@en

Somatostatin analogs for the treatment of neuroendocrine tumors.

@nl

P1433

Q37849210-9CE5D5DC-E11E-40F3-A0C1-CDE055F9DEA3

P1476

Q37849210-DFD925B9-AD05-4A0E-8868-F5D7B4B5CC21

P2093

Q37849210-91EE76B2-E416-403D-94D8-697D38FD5A6E

Q37849210-AD9D89CC-0BC1-455D-9BF5-3C2BC2DB9524

Q37849210-B0366325-8942-41A9-B2F1-927EAEEE8450

Q37849210-E98EB172-99FA-487B-AAF6-B7C98DDC5BD6

Q37849210-EE940642-491B-4791-977C-0CD452E1EFD2

P2860

Q37849210-00EEA0E6-7343-4329-9EF1-003B9C6908EB

Q37849210-0495DDFC-2E4D-4348-A4D9-77EF4F45C9A7

Q37849210-0784C0F6-6006-4EB4-8E80-230FFBFBF792

Q37849210-09DC569C-4E6D-486E-82FB-52CBF1667A9F

Q37849210-0B2D9D86-35F4-4F46-910B-91F519C5BD39

Q37849210-0DCB8CE4-5187-4CE9-A52C-46401ADB43C5

Q37849210-12D87AD8-A848-4A77-833B-8F87AFFC868E

Q37849210-16570917-7B56-4989-9AF3-42209A61CC4A

Q37849210-16B93E45-2AE2-4F48-9F4A-F5D55642B773

Q37849210-1ACEC825-2A24-47D5-89D2-D9AF3B8C6648

P2888

Q37849210-3EEB54C7-E323-487D-B338-DFDF7E9FC6B2

P304

Q37849210-02E696A5-CD71-4EF7-BDE5-F63DE0FBFFD6

P31

Q37849210-A114B089-2768-4C4E-A1F9-28818519FCD8

P356

Q37849210-856F9098-57EE-42C9-B00A-7E9022C11352

P478

Q37849210-F2859234-BF73-40A6-82F1-825FB09AD0C8

P50

Q37849210-DCFD02E4-5FDA-480D-A7FC-0CF99402AEA2

P577

Q37849210-A57E0EA9-1461-4CBB-8729-BDDE670EA84D

P698

Q37849210-F5C83BA0-B4CF-4450-834F-1D6A6BE62066

P356

S10555-011-9293-0

P1433

Cancer and Metastasis Reviews

P1476

Somatostatin analogs for the treatment of neuroendocrine tumors

@en

P2093

Eric P Krenning

http://www.w3.org/2001/XMLSchema#string

Isabel Sevilla

http://www.w3.org/2001/XMLSchema#string

José Angel Díaz

http://www.w3.org/2001/XMLSchema#string

Kjell Oberg

http://www.w3.org/2001/XMLSchema#string

Rudolf Arnold

http://www.w3.org/2001/XMLSchema#string

P2860

Targeting tumorigenesis: development and use of mTOR inhibitors in cancer therapy

Subtypes of the somatostatin receptor assemble as functional homo- and heterodimers

Rationale for the use of somatostatin analogs as antitumor agents

A comparison of the effects of gastrin, somatostatin and dopamine receptor ligands on rat gastric enterochromaffin-like cell secretion and proliferation

Bim-23244, a somatostatin receptor subtype 2- and 5-selective analog with enhanced efficacy in suppressing growth hormone (GH) from octreotide-resistant human GH-secreting adenomas.

Report on short-term side effects of treatments with 177Lu-octreotate in combination with capecitabine in seven patients with gastroenteropancreatic neuroendocrine tumours

Somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine tumours, current aspects and new perspectives.

Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity.

Receptor targeting for tumor localisation and therapy with radiopeptides.

Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone.

P2888

s10555-011-9293-0

P304

9-17

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10555-011-9293-0

http://www.w3.org/2001/XMLSchema#string

P478

30 Suppl 1

http://www.w3.org/2001/XMLSchema#string

P50

Michael D. Culler

P577

2011-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21369878

http://www.w3.org/2001/XMLSchema#string